The Deal - Dealmaking Insights & Analysis

M&A

Post-Merger T-Mobile Won’t Be Maverick: States’ Expert

By Chris Nolter

Published: December 12th, 2019

An expert witness for the group of states suing to block T-Mobile's purchase of Sprint testified that the post-merger company would likely lose its zeal for aggressive price competition.

Private Equity

Middle-Market Digest: How Olympus Sourced Heniff and More

By Steve Gelsi

Published: December 12th, 2019

A compilation of middle market and growth equity deals under $500 million between Nov. 22 and Dec. 5.

Private Equity

Family Offices and PE: Can’t We All Get Along

Published: December 11th, 2019

M&A

Merck Expands Oncology Pipeline With ArQule

Published: December 9th, 2019

The biopharmaceutical giant is paying a 107% premium for the target, which focuses on therapies for treating cancer and rare diseases.

M&A

Drinks With The Deal: Chris Varelas

By David Marcus

Published: December 6th, 2019

The former Citi tech investment banker and author of 'How Money Became Dangerous' talks with The Deal’s David Marcus about working at Disneyland in the 1980s, being a tech banker after the dot-com crash and investing in influencers.

Activism

Inside Hudson Executive’s USA Tech Battle

By Ronald Orol

Published: December 6th, 2019

The activist fund’s mission statement says it won't launch public proxy fights, but Hudson Executive nevertheless is set for one at the digital payments technology company.

M&A

Thoma Bravo Takes Instructure Private Following Review

By Steve Gelsi

Published: December 4th, 2019

The $2 billion bid comes after the company announced a strategic review in October and after The Deal named the information tech company a target in January.

M&A

Discipline Crucial in 2020

By Alexandra Garfinkle

Published: December 2nd, 2019

M&A valuations remain frothy and Ebitda adjustments are growing, panelists cautioned at The 2019 Deal Economy Conference.